Antifungal activity of the new agent latoconazole in two tinea models.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Arzneimittel-Forschung

• Publication date

  1991-08-01

• Fields of study

  Medicine

• Identifiers
  PMID 1781809
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental tinea pedis induced by non-abrasive inoculation of Trichophyton mentagrophytes arthrospores on the plantar part of a guinea pig foot.

  1987cited by this paper
• Prophylaxis of tinea pedis interdigitalis with bifonazole, 1% powder.

  1984cited by this paper
• In vivo activity of bifonazole in guinea pigs: its characteristic features and comparison with clotrimazole.

  1984cited by this paper
• Antimycotic efficacy of bifonazole in vitro and in vivo.

  1983cited by this paper
• In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole.

  1983cited by this paper
• A comparison of bifonazole (BAY H 4502) with clotrimazole in vitro.

  1982cited by this paper
• The production of experimental dermatophyte lesions in guinea pigs.

  1979cited by this paper
• A quantitative dermatophyte infection model in the guinea pig--a parallel to the quantitated human infection model.

  1976cited by this paper
• [Experimental study of the antimycotic effect of clotrimazole in vitro and in vivo when administered locally].

  1972cited by this paper

• Treatment of skin disorders with Aloe materials.

  2019cites this paper
• Anti‐inflammatory activity of lanoconazole, a topical antifungal agent

  2015cites this paper
• Animal Model of Dermatophytosis

  2012cites this paper
• Guinea Pigs as Experimental Models

  2012cites this paper
• Animal Models of Human Pathology 2012

  2012cites this paper
• Dose‐finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis – comparison between three groups (1%, 0.5%, 0.1%) by a multi‐center randomised double‐blind study

  2007cites this paper
• A comparative clinical study between 2 weeks of luliconazole 1% cream treatment and 4 weeks of bifonazole 1% cream treatment for tinea pedis

  2006cites this paper
• Achievement of Complete Mycological Cure by Topical Antifungal Agent NND‐502 in Guinea Pig Model of Tinea Pedis

  2003cites this paper
• Usefulness of Lanoconazole (Astat®) cream in the treatment of hyperkeratotic type tinea pedis. Comparative study of monotherapy and combination therapy with 10% Urea Ointment (Pastaron®)

  2001cites this paper
• In Vitro Antifungal Activity of KP-103, a Novel Triazole Derivative, and Its Therapeutic Efficacy against Experimental Plantar Tinea Pedis and Cutaneous Candidiasis in Guinea Pigs

  2001cites this paper
• Comparison of the therapeutic efficacy of oral doses of fluconazole and griseofulvin in a guinea pig model of dermatophytosis.

  2000cites this paper
• Selected animal models: vaginal candidosis, Pneumocystis pneumonia, dermatophytosis and trichosporosis.

  1998cites this paper
• In vivo effects of Aloe arborescens Miller var. natalensis Berger (Kidachi aloe) on experimental tinea pedis in guinea‐pig feet

  1998cites this paper
• An Overview of Topical Antifungal Therapy in Dermatomycoses

  1998cites this paper
• In Vitro and In Vivo Antidermatophyte Activities of NND-502, a Novel Optically Active Imidazole Antimycotic Agent

  1998cites this paper
• Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Distribution in the skin and in vitro activity in the presence of stratum corneum.

  1997cites this paper
• Animal Models of Dermatomycoses in Recent Years

  1997cites this paper
• Wound healing effect of the new imidazole antimycotic lanoconazole in rats.

  1996cites this paper
• Allergic contact dermatitis from lanoconazole

  1996cites this paper
• Short-term topical therapy of experimental tinea pedis in guinea pigs with lanoconazole, a new imidazole antimycotic agent

  1995cites this paper
• Therapeutic efficacy of lanoconazole, a new imidazole antimycotic agent, for experimental cutaneous candidiasis in guinea pigs

  1994cites this paper
• Evaluation of the Viability of Trichophyton mentagrophytes

  1993cites this paper
• In vitro Anti-Malassezia Activity of NND-318

  1992cites this paper
• Inhibitory Effect of NND-318 on Ergosterol Synthesis in Trichophyton mentagrophytes and Candida albicans

  1992cites this paper
• Prophylactic Effect of NND-318, a New Antimycotic, on Experimental Dermatophytosis in Guinea Pigs

  1992cites this paper
• In vitro Antifungal Activity of NND-318, a New Imidazole Antimycotic, against Clinical Isolates from Patients with Cutaneous Mycosis

  1992cites this paper
• Therapeutic efficacy of latoconazole in formulations of clinical use on experimental dermatophytosis in guinea pigs.

  1992cites this paper
• II phase clinical trial of TJN-318 liquid for dermatomycosis.

  1992cites this paper
• In vitro Antifungal Activity of NND-318, a New Antimycotic

  1992cites this paper
• Prophase II phase clinical trial of TJN-318 cream for dermatomycosis.

  1992cites this paper
• Effect of NND-318 on the Ultrastructure of Trichophyton mentagrophytes as Observed by Scanning and Transmission Electron Microscopy

  1991cites this paper